PERIPHERAL ARTERIES  UPDATE ON MANAGEMENT OF CAROTID, AORTIC AND PERIPHERAL ARTERIAL PATHOLOGIES 

The Journal of Cardiovascular Surgery 2015 April;56(2):309-16

Copyright © 2015 EDIZIONI MINERVA MEDICA

language: English

State-of-the-art treatment of common femoral artery disease

Nasr B. ¹, Kaladji A. ², Vent P. A. ², Chaillou P. ^{2, 4}, Costargent A. ^{2, 4}, Patra P. ^{2, 3}, Quillard T. ^{3, 4}, Gouëffic Y. ^{2, 3, 4} ✉

¹ CHU de Brest, Service de Chirurgie Vasculaire, Brest, France; ² CHU Nantes, l’Institut du Thorax, Service de Chirurgie Vasculaire, Nantes, France; ³ Université de Nantes, Nantes, France; ⁴ INSERM, U957, Nantes, France

Atherosclerotic common femoral artery (CFA) disease is a well-known and frequent cause of symptomatic peripheral artery disease (PAD). Not so long ago, surgical treatment was considered the gold standard and the main treatment option. Therapeutic advances have, however, provided a wide and suitable armamentarium. These advances concern medical treatment and the direct treatment of lesions by open surgery or endovascular treatment. The aim of this manuscript was to summarize therapeutic updates and to describe the current endovascular and open surgical procedures used to treat common femoral artery disease.